Skip to main content

By mid-year, Mass. life science M&A tops $22.5B

Midway through 2019, more than a dozen local biotechs and medical device firms have made business sales, acquisitions or merged with other companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.